EXIT STRATEGY IN A TREAT-AND-EXTEND REGIMEN FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION [PDF]
Retina, 2019 Purpose: To evaluate the outcome of an exit strategy in a treat-and-extend regimen for neovascular age-related macular degeneration. Methods: Five hundred and ninety-eight eyes of 488 patients with neovascular age-related macular degeneration receiving intravitreal anti–vascular ...
Arendt P +5 more
openaire +3 more sources
Efficacy and Safety of Intravitreal Aflibercept Treat and Extend for Polypoidal Choroidal Vasculopathy in the ATLANTIC Study: A Randomized Clinical Trial [PDF]
, 2022 Aflibercept; Efficacy; Polypoidal choroidal vasculopathyAflibercept; Eficacia; Vasculopatía coroidea polipoideaAflibercept; Eficàcia; Vasculopatia coroidal polipoidalImportance: Polypoidal choroidal vasculopathy (PCV) is far less common and studied in a ...
Arias, Luis +6 more
core +1 more source
BMC Ophthalmology, 2021 Purpose To describe real-life data from wet age-related macular degeneration (AMD) patients treated with anti-vascular endothelial growth factors (VEGFs) and to compare our results with previous studies and clinical trials.
Paolo Corazza +6 more
doaj +1 more source
Pediatric pulmonary mucormycosis in a diabetic patient treated with extended pleurectomy and Clagett procedure [PDF]
Journal of Pediatric Surgery Case Reports, 2019 Mucor is a ubiquitous fungus that is non-pathogenic in healthy people. In immunocompromised hosts, non-functional or absent neutrophils and macrophages result in fungal invasion and infection [1]. Invasive mucor (mucormycosis) most commonly involves the sinuses, brain, or lungs.
Gologorsky, Rebecca C +4 more
openaire +3 more sources
Analysis of Choroidal Thickness in Age-Related Macular Degeneration Using Spectral-Domain Optical Coherence Tomography [PDF]
, 2011 Purpose To understand the relationship between choroidal thickness and various disease factors in patients with age-related macular degeneration (AMD) using spectral-domain optical coherence tomography. Design Cross-sectional, retrospective analysis.
Duker, Jay S. +3 more
core +1 more source
Anti-vascular endothelial growth factor for diabetic macular oedema. [PDF]
, 2014 BACKGROUND: Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Although grid or focal laser photocoagulation has been shown to reduce the risk of visual loss in DMO, or clinically significant macular oedema (CSMO), vision is ...
Evans, Jennifer R +3 more
core +1 more source
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration [PDF]
, 2018 Individualized treatment regimens may reduce patient burden with satisfactory patient outcomes in neovascular age-related macular degeneration. Intravitreal anti-VEGF drugs are the current gold standard.
Araiz, Javier +13 more
core +1 more source
Treat and extend regimen with aflibercept for choroidal neovascularization in angioid streaks [PDF]
Eye, 2016 Treat and extend regimen with aflibercept for choroidal neovascularization in angioid ...
openaire +1 more source
Prospective study evaluating the predictability of need for retreatment with intravitreal ranibizumab for age-related macular degeneration [PDF]
, 2018 Purpose: To investigate the rhythm and predictability of the need for retreatment with intravitreal injections of ranibizumab for neovascular age-related macular degeneration (nAMD).
Ambresin, Aude +3 more
core
Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registry [PDF]
, 2022 Purpose To compare the outcomes of two different antivascular endothelial growth factor treatment regimens for treatment-naive eyes with neovascular age-related macular degeneration in routine clinical care at 12 and 24 months in Spain.
Barthelmes, Daniel +7 more
core +1 more source